4//SEC Filing
Cruse Michael 4
Accession 0001209191-22-048534
CIK 0001637715other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 5:12 PM ET
Size
5.8 KB
Accession
0001209191-22-048534
Insider Transaction Report
Form 4
Cruse Michael
Senior VP-Corporate Operations
Transactions
- Purchase
Common Stock
2022-09-01$3.39/sh+7,500$25,448→ 13,697 total(indirect: By Trust)
Holdings
- 31,758
Common Stock
Footnotes (2)
- [F1]The weighted average purchase price for the transaction was $3.393. The shares were purchased at a range of prices between $3.36 and $3.48. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F2]By Michael P. Cruse and Thu Anh Thuy Cruse, Trustees of The Cruse Family Revocable Living Trust.
Documents
Issuer
Reneo Pharmaceuticals, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001854179
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 5:12 PM ET
- Size
- 5.8 KB